Goals · Body & Composition
Lose body fat while preserving lean tissue. Most approaches combine appetite control, lipolysis support, and metabolic optimization.
Compounds linked to this goal in the catalogue, ordered by role — primary, then support, then optional. Click any card for the full mechanism, dosing, and evidence.
NNMT Inhibitor | Longevity & Metabolic Enhancement
Half-life: 4-7 hours (3.8h IV, 6.9h oral)
Prohibitin-Targeting Peptidomimetic | Experimental Anti-Obesity
Half-life: Not established
Modified hGH Fragment | Fat Loss Peptide
Half-life: 3-4 minutes
Long-Acting Amylin Receptor Agonist | Weight Loss & Diabetes
Half-life: ~7 days (159-195 hours)
Growth Hormone Fragment | Fat Loss Peptide
Half-life: 15-20 minutes
Dual GLP-1/Glucagon Receptor Agonist | Weight Loss & Diabetes
Half-life: 6-8 days
Oral Small-Molecule GLP-1 Receptor Agonist | Weight Loss & Diabetes
Half-life: 25-68 hours
Triple GLP-1/GIP/Glucagon Agonist | Weight Loss & Diabetes
Half-life: ~6 days
GLP-1 Receptor Agonist | Weight Loss & Diabetes
Half-life: ~7 days (168 hours)
Dual GLP-1/Glucagon Receptor Agonist | Weight Loss & Diabetes
Half-life: Approximately 6 days (109-115 hours)
GHRH Analog | Visceral Fat Reduction
Half-life: 26-38 minutes
Dual GIP/GLP-1 Receptor Agonist | Weight Loss & Diabetes
Half-life: ~5 days (120 hours)
No SARMs tagged for this goal yet.